Cargando…
Heart Protection by Combination Therapy with Esmolol and Milrinone at Late-Ischemia and Early Reperfusion
INTRODUCTION: The present study determined whether late-ischemia/early reperfusion therapy with the β(1)-adrenergic receptor (AR) blocker esmolol and phosphodiesterase III inhibitor milrinone reduced left ventricular (LV) myocardial infarct size (IS). METHODS AND RESULTS: In an ischemia/reperfusion...
Autores principales: | Huang, Ming-He, Wu, Yewen, Nguyen, Vincent, Rastogi, Saurabh, McConnell, Bradley K., Wijaya, Cori, Uretsky, Barry F., Poh, Kian-Keong, Tan, Huay-Cheem, Fujise, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110274/ https://www.ncbi.nlm.nih.gov/pubmed/21562974 http://dx.doi.org/10.1007/s10557-011-6302-z |
Ejemplares similares
-
ST-segment elevation myocardial infarction hospitalisations remain unchanged during COVID-19
por: Koo, Chieh Yang, et al.
Publicado: (2020) -
Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice
por: Jung, Hong Soo, et al.
Publicado: (2014) -
Milrinone: Is Bolus Bad?
por: Kulkarni, Venugopal
Publicado: (2018) -
Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4
por: Poh, Kian Keong, et al.
Publicado: (2020) -
The antinociceptive effect of esmolol
por: Kim, Yoon Hee
Publicado: (2010)